AI-generated summary
The authors studied 50 patients with melasma who received weekly low-fluence 1064 nm Q-switched Nd:YAG laser treatments for 15 weeks. Patients and investigators rated the outcome as good improvement, with improvement rates of 50 to 74 percent, and a pigment imaging tool supported the change. The authors report no severe side effects, though the abstract describes a single-arm study without a control group.
- Participants
- 50
- Who or what was studied
- Fifty Asian patients with melasma
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract describes a single-group study without a control group, and the outcome was largely based on subjective ratings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.